US EditionBlood test for early signs of pancreatic cancer trialled by UK doctors
ENGLAND, UNITED KINGDOM, JUN 16 – The Avantect test shows 68% accuracy in early pancreatic cancer detection among new type 2 diabetes patients, aiming to improve survival through earlier diagnosis in a UK pilot.
- The NHS started a pilot project led by consultant surgeon Zaed Hamady to detect pancreatic cancer early using blood tests and CT scans for people over 60.
- The pilot arose because pancreatic cancer symptoms often appear late, leading to late diagnosis and poor survival rates, with around 10,500 diagnosed yearly in the UK.
- The program involves more than 300 GP practices identifying patients with recent diabetes diagnosis or sudden weight loss for urgent testing to improve detection.
- The blood test, approved by ClearNote Health, correctly identifies early-stage cases 68% of the time and accurately rules out individuals who do not have the disease 97% of the time.
- If successful, the pilot could improve early diagnosis and survival for a cancer where most patients currently die within months, prompting calls for faster diagnoses across the UK.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
All
Left
3
Center
7
Right
2
Pancreatic cancer is one of the most lethal diseases and is almost too late to be treated more effectively. A new innovative genetic test, found at the test stage in the British Sea, promises to change this reality. Designed...
·Romania
Read Full Article
Coverage Details
Total News Sources23
Leaning Left3Leaning Right2Center7Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
L 25%
C 58%
R 17%
Factuality
To view factuality data please Upgrade to Premium
